AUROPHARMA — Aurobindo Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual balance sheet for Aurobindo Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	56,212	45,576	62,327	63,264	82,013
Net Total Accounts Receivable
Net Total Receivables	50,548	58,830	66,871	76,258	83,743
Total Inventory
Total Other Current Assets
Total Current Assets	198,235	181,227	215,457	242,056	271,625
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	93,155	106,660	124,918	142,849	154,554
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	338,540	339,217	398,900	450,715	497,850
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	106,652	81,560	114,938	121,991	146,823
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	119,241	93,457	130,501	152,287	171,317
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	219,299	245,760	268,399	298,428	326,533
Total Liabilities & Shareholders' Equity	338,540	339,217	398,900	450,715	497,850
Total Common Shares Outstanding